Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
4(36%)
Results Posted
50%(1 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_2
2
18%
Ph not_applicable
1
9%
Ph phase_3
2
18%
Ph phase_4
1
9%

Phase Distribution

0

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
2(33.3%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

4

trials recruiting

Total Trials

11

all time

Status Distribution
Active(5)
Completed(2)
Terminated(1)
Other(3)

Detailed Status

unknown3
Recruiting3
Completed2
Terminated1
Active, not recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
4
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (33.3%)
Phase 32 (33.3%)
Phase 41 (16.7%)
N/A1 (16.7%)

Trials by Status

terminated19%
unknown327%
completed218%
active_not_recruiting19%
enrolling_by_invitation19%
recruiting327%

Recent Activity

4 active trials
Showing 5 of 11
enrolling_by_invitation

Surgical Outcomes in Splenic Flexure Cancers: A Multicenter Comparison of Segmental vs. Extended Hemicolectomy (SPARROW Study)

NCT07289568
active_not_recruitingphase_2

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

NCT06124378
recruiting

Prevalence and Impact of Sarcopenia in Patients With Inflammatory Bowel Disease

NCT06300541
completed

Outpatient Left Laparoscopic Colectomy

NCT04310839
recruitingphase_2

Induction Chemotherapy Combined With Neoadjuvant Immunotherapy for MSS Colon Cancer

NCT05914389
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT07289568

Surgical Outcomes in Splenic Flexure Cancers: A Multicenter Comparison of Segmental vs. Extended Hemicolectomy (SPARROW Study)

Enrolling By Invitation
NCT06124378Phase 2

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

Active Not Recruiting
NCT06300541

Prevalence and Impact of Sarcopenia in Patients With Inflammatory Bowel Disease

Recruiting
NCT04310839

Outpatient Left Laparoscopic Colectomy

Completed
NCT05914389Phase 2

Induction Chemotherapy Combined With Neoadjuvant Immunotherapy for MSS Colon Cancer

Recruiting
NCT05424939

Management of Obstructive Colon Tumors in Istanbul

Unknown
NCT05194878Phase 3

Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers

Recruiting
NCT01536535Phase 4

Predicting Response to Standardized Pediatric Colitis Therapy

Completed
NCT03380858

REINFORCEMENT ANASTOMOSIS WITH Modified Cyanacrylate IN Patients Undergoing to Oncologic Colorectal Surgery With Colorectal Anastomosis

Unknown
NCT02363049Phase 3

Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon Cancer

Unknown
NCT00419978Not Applicable

The Significance of Sentinel Node Analysis in Colon Cancer

Terminated

All 11 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
11